终末期肾脏病新入血液透析患者3个月内死亡危险因素分析

    Risk factors predict death within the first 3 months for hemodialysis patients with end stage renal disease

    • 摘要: 目的 分析终末期肾脏病(ESRD)新入血液透析患者3个月内死亡的原因,探讨影响血液透析患者3个月内生存的相关危险因素,为提高血液透析患者3个月内生存率提供研究思路。方法 纳入2010年1月1日至2013年12月31日期间四川大学华西医院肾脏科所有ESRD新入血液透析患者,随访至2017年3月1日,将所有进入透析后3个月内死亡的患者作为研究组,将所有存活大于3个月患者作为对照组。比较两组患者进入透析时基本情况、实验室检查等,采用Logistic回归模型分析相关危险因素。结果 纳入研究的ESRD新入血液透析患者1268例,随访期死亡438例,基础疾病主要为:慢性肾小球肾炎(50.47%)、糖尿病(23.03%)、高血压病(9.31%)。新入患者死亡高峰在进入透析3个月内出现,共155例,占所有死亡患者的35.4%。3个月内死亡患者基础疾病主要为:糖尿病(32.26%)、慢性肾小球肾炎(23.23%),高血压病(15.48%)。Logistic分析提示进入透析时查尔森合并症指数(Charlson comorbidity index)较高、基础疾病为糖尿病、中性粒细胞比率升高、病程中曾接受连续性血液净化(CRRT)治疗比例更高、红细胞分布宽度增高是新入血液透析患者3月内死亡的危险因素;较高的血清白蛋白与高密度脂蛋白是保护性因素。研究人群中基础疾病为糖尿病患者292例,3月内死亡50例(17.1%),存活超过3个月的242例(82.9%)。Logistic分析提示病程中曾接受CRRT治疗、更高的查尔森合并症指数、中性粒细胞比率更高是基础疾病为糖尿病患者3个月内死亡的危险因素。结论 ESRD新入血液透析患者在开始3个月内死亡风险较高。积极治疗患者的合并症、改善患者低蛋白状况可能有助于提高患者早期生存率。糖尿病是ESRD患者常见原发病因和死亡危险因素之一,值得关注。

       

      Abstract: Objective To analyze the causes of death in ESRD patients undergoing HD who died within the first 3 months of hemodialysis, and to explore the risk factors affecting survival, thus to provide some potential ways to improve the survival of HD patients, especially for the survival within the first 3 months. Methods All patients with ESRD starting hemodialysis between January 1,2010 to December 31, 2013 in Department of Nephrology, West China Hospital were included and followed-up until March 1, 2017. Baseline characteristics and laboratory results of patient who died within the first 3 months and patients who survived the first 3 months were analyzed. Logistic regression was used to analysis the risk factors associated with death within the first 3 months. Results Four hundred and thirty-eight cases in total 1268 HD patients died in the study period, among which 155 patients died within the first 3 months after the beginning of hemodialysis, characterized as the peak of death occurred within the first 3 months, accounting for 35.4% of all died HD patients. The top three primary causes for renal diseases were as follows:chronic glomerulonephritis (50.47%), diabetes (23.03%) and hypertension (9.31%). For those patients who died within the first 3 months, the top three primary causes of renal diseases were as follows:diabetes (32.3%), chronic glomerulonephritis (23.2%), hypertension (15.4%). Logistic regression analysis showed that increased Charlson comorbidity index (CCI), diabetes as primary cause of renal diseases, increased neutrophil ratio, red blood cell distribution width, continuous renal replacement therapy (CRRT)were risk factors of death within the first 3 months, whereas serum albumin, high-density lipoprotein cholesterol were protective factors. The number of patients whose primary causes of renal disease were diabetes were 292. Fifty patients died within the first 3 months, and 242 patients survived longer. CCI, CRRT, higher neutrophil ratio were risk factors for patients whose primary causes of renal disease were diabetes. Compared with the patient with chronic glomerulonephritis, the common risk factor was CRRT. The unique risk factor of patient with chronic characterized was red blood cell distribution width and the unique protection factor is higher HDL. Conclusions The risk of death within the first 3 months of hemodialysis is high. Active treatment of patients' complications and low protein status may help to improve the early survival rate of patients. Diabetes is one of the common primary causes and death risk factors in ESRD patients, which deserves attention.

       

    /

    返回文章
    返回